FUTU:OTCQB-Future Healthcare Of Amer (USD)

COMMON STOCK | Capital Markets | OTCQB - U.S. Registered

Last Closing

USD 66.38

Change

+3.38 (+5.37)%

Market Cap

USD 0.90M

Volume

3.06M

Analyst Target

USD 37.62
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Future Healthcare Of America provides healthcare services. It is engaged in homecare and staffing operations. Its home care services include senior care and pediatric nursing, and physical, occupational & speech therapy.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Capital Markets

Symbol Name Price(Change) Market Cap
IBKR Interactive Brokers Group Inc

-0.82 (-0.68%)

USD 48.41B
TW Tradeweb Markets Inc

+0.92 (+0.83%)

USD 22.75B
LPLA LPL Financial Holdings Inc

-1.94 (-0.72%)

USD 19.89B
HOOD Robinhood Markets Inc

-0.14 (-0.78%)

USD 14.54B
MKTX MarketAxess Holdings Inc

+1.32 (+0.66%)

USD 7.64B
MARA Marathon Digital Holdings Inc

-0.12 (-0.59%)

USD 5.20B
FRHC Freedom Holding Corp

-1.60 (-2.26%)

USD 4.09B
CLSK CleanSpark Inc

-0.17 (-1.03%)

USD 3.81B
VIRT Virtu Financial Inc

+0.06 (+0.27%)

USD 3.48B
BGC BGC Group Inc.

+0.10 (+1.14%)

USD 3.39B

ETFs Containing FUTU

EMFQ Amplify ETF Trust - Ampli.. 3.53 % 0.00 %

-0.12 (-0.55%)

USD 1.98M
EWH iShares MSCI Hong Kong ET.. 0.00 % 0.48 %

-0.25 (-0.55%)

USD 0.49B
GENY 0.00 % 0.45 %

N/A

N/A
XBUY 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Capital Markets) Market Performance vs. Exchange (OTCQB - U.S. Registered)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 21.51% 86% B+ 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 21.51% 86% B+ 84% B
Trailing 12 Months  
Capital Gain 49.94% 78% C+ 88% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 49.94% 78% C+ 88% B+
Trailing 5 Years  
Capital Gain 94,728.57% 100% F 100% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 94,728.57% 100% F 100% F
Average Annual (5 Year Horizon)  
Capital Gain 1,654.48% 96% N/A 99% N/A
Dividend Return 1,654.48% 96% N/A 99% N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 6,594.04% 6% D- 1% F
Risk Adjusted Return 25.09% 68% D+ 61% D-
Market Capitalization 0.90M 89% A- 91% A-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.